Yüklüyor......
Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib
Advances in our understanding of renal cancer biology have led to a new treatment paradigm in renal cancer. Tyrosine kinase inhibitors (TKI), that target the intracellular kinase domain of the VEGF receptor, have become established as the most successful class of agent in this disease. Three TKIs ar...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Libertas Academica
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3210627/ https://ncbi.nlm.nih.gov/pubmed/22084622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S7263 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|